Close Menu

NEW YORK (360Dx) – University of Huddersfield researchers have identified a pair of metabolomic biomarkers for multiple sclerosis.

In a study published in Analytical Methods in September, the scientists used mass spec to compare the serum metabolomes of multiple sclerosis patients and controls and identified two markers, sphingosine and dihydrosphingosine, that were significantly downregulated in patients with MS.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.